Concomitant Chlamydia Trachomatis and Human Papilloma Virus Infection Cannot Be Attributed Solely to Sexual Behaviour

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2004 Aug 24

PMID 15322933

Citations 3

Authors

V Verhoeven

M Baay

J Weyler

D Avonts

F Lardon

P Van Royen

J B Vermorken

Affiliations

Soon will be listed here.

Citing Articles

Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytology.

Panatto D, Amicizia D, Bianchi S, Frati E, Zotti C, Lai P Hum Vaccin Immunother. 2014; 11(1):270-6.

PMID: 25483545 PMC: 4514400. DOI: 10.4161/hv.36163.

Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.

Hwang L, Ma Y, Shiboski S, Farhat S, Jonte J, Moscicki A J Infect Dis. 2012; 206(4):504-11.

PMID: 22696500 PMC: 3491738. DOI: 10.1093/infdis/jis398.

The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda.

Veldhuijzen N, Braunstein S, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E BMC Infect Dis. 2011; 11:333.

PMID: 22136570 PMC: 3247865. DOI: 10.1186/1471-2334-11-333.

References

Verhoeven V, Avonts D, Meheus A, Goossens H, Ieven M, Chapelle S . Chlamydial infection: an accurate model for opportunistic screening in general practice. Sex Transm Infect. 2003; 79(4):313-7. PMC: 1744692. DOI: 10.1136/sti.79.4.313. View

Baay M, Lardon F, Vermorken J, Verhoeven V, Avonts D, Van Royen P . HPV in cervix and vagina. Sex Transm Infect. 2004; 80(3):249-50. PMC: 1744825. DOI: 10.1136/sti.2003.008383. View

Sellors J, Karwalajtys T, Kaczorowski J, Mahony J, Lytwyn A, Chong S . Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ. 2003; 168(4):421-5. PMC: 143547. View

Munoz N, Kato I, Bosch F, Eluf-Neto J, de Sanjose S, Ascunce N . Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis. 1996; 23(6):504-10. DOI: 10.1097/00007435-199611000-00012. View

Tamim H, Finan R, Sharida H, Rashid M, Almawi W . Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis. 2002; 43(4):277-81. DOI: 10.1016/s0732-8893(02)00403-0. View

Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I . Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001; 285(1):47-51. DOI: 10.1001/jama.285.1.47. View

Schachter J, McCormack W, Chernesky M, Martin D, Van Der Pol B, Rice P . Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol. 2003; 41(8):3784-9. PMC: 179798. DOI: 10.1128/JCM.41.8.3784-3789.2003. View

Jha P, Beral V, Peto J, Hack S, Hermon C, Deacon J . Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet. 1993; 341(8853):1116-8. DOI: 10.1016/0140-6736(93)93128-n. View

Morre S, van den Brule A, Rozendaal L, Boeke A, Voorhorst F, de Blok S . The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS. 2003; 13 Suppl 2:12-8. DOI: 10.1258/095646202762226092. View

10.

Hillemanns P, Kimmig R, HUTTEMANN U, Dannecker C, Thaler C . Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet. 2000; 354(9194):1970. DOI: 10.1016/s0140-6736(99)04110-0. View

11.

Finan R, Tamim H, Almawi W . Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet. 2002; 266(3):168-71. DOI: 10.1007/s00404-001-0261-8. View

12.

Baay M, Smits E, Tjalma W, Lardon F, Weyler J, Van Royen P . Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer. 2003; 108(2):258-61. DOI: 10.1002/ijc.11543. View

13.

Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M . Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol. 2001; 39(5):1751-6. PMC: 88020. DOI: 10.1128/JCM.39.5.1751-1756.2001. View

14.

Zhong G, Fan P, Ji H, Dong F, Huang Y . Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med. 2001; 193(8):935-42. PMC: 2193410. DOI: 10.1084/jem.193.8.935. View

15.

Franco E, Ferenczy A . Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001; 164(7):1017-25. PMC: 80931. View

16.

Castellsague X, Bosch F, Munoz N . Environmental co-factors in HPV carcinogenesis. Virus Res. 2002; 89(2):191-9. DOI: 10.1016/s0168-1702(02)00188-0. View

17.

Smith J, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S . Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis. 2002; 185(3):324-31. DOI: 10.1086/338569. View

18.

Mavoungou E, Toure F, Sall A, Delicat A, Yaba P, Mandeme Y . Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals. Trop Med Int Health. 1999; 4(11):719-27. DOI: 10.1046/j.1365-3156.1999.00479.x. View

19.

Wallin K, Wiklund F, Luostarinen T, Angstrom T, Anttila T, Bergman F . A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer. 2002; 101(4):371-4. DOI: 10.1002/ijc.10639. View